American Academy of Child and Adolescent Psychiatry GUIDELINES Apps

ADHD

AACAP Clinical GUIDELINES App brought to you free of charge courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/100163

Contents of this Issue

Navigation

Page 10 of 11

FDA Maximum/Day 40 mg Comments >> Short-acting stimulants often used as initial treatment in small children (< 16 kg), but have disadvantage of bid-tid dosing to control symptoms throughout day. >> Longer-acting stimulants offer greater convenience, confidentiality, and compliance with single daily dosing, but may have greater problematic effects on evening appetite and sleep. >> Adderall XR cap may be opened and sprinkled on soft food. 30 mg 40 mg 70 mg 20 mg 30 mg 60 mg 60 mg >> Short-acting stimulants often used as initial treatment in small children (< 16 kg), but have disadvantage of bid-tid dosing to control symptoms throughout day. >> Longer-acting stimulants offer greater convenience, confidentiality, and compliance with single daily dosing, but may have greater problematic effects on evening appetite and sleep. >> Metadate CD, Ritalin LA, and Focalin XR may be opened and sprinkled on soft food. >> Concerta tab should be swallowed whole with liquids. >> Concerta nonabsorbable tab shell may be seen in stool. 72 mg 30 mg Lesser of 1.4 mg/kg or 100 mg >> Consider if active substance abuse or severe side effects of stimulants (mood liability, tics). >> Give q am or divided doses bid (effects on late evening behavior). >> Do not open cap. >> Monitor closely for suicidal thinking and behavior, clinical worsening, or unusual changes in behavior. >> Not a Schedule II medication. 0.4 mg >> Taper when discontinuing ��� 0.1 mg q3-7d 4 mg 9

Articles in this issue

Archives of this issue

view archives of American Academy of Child and Adolescent Psychiatry GUIDELINES Apps - ADHD